Latest hypoglycemia Stories
Newer technologies designed to help people with type 1 diabetes monitor their blood sugar levels daily work better than traditional methods and require fewer painful needle sticks
Type 2 diabetes often reverses after modified weight loss surgery, especially when the duration of diabetes is less than 10 years.
The diabetes drug sitagliptin appears to reduce the severity of reactive hypoglycemia, a form of low blood sugar that occurs after a meal.
An experimental insulin drug prevented low blood sugar among diabetic patients more often than a popular drug on the market.
In the first systematic review of its kind, new research shows that strictly monitoring blood glucose levels (enhanced glucose control) with the right target levels can prevent diabetic neuropathy.
JDRF-funded researchers at Oregon Health & Science University (OHSU) and Legacy Health have discovered a liquid glucagon formulation that may be useable in standard diabetes pumps. Such a formulation could broaden the use of glucagon to help prevent hypoglycemia in people with type 1 diabetes (T1D) who are treated with insulin.
Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...
- A person in a secondary role, specifically the second most important character (after the protagonist).